Search

Your search keyword '"Bristol-Myers Squibb Co. -- Forecasts and trends"' showing total 1,053 results

Search Constraints

Start Over You searched for: Descriptor "Bristol-Myers Squibb Co. -- Forecasts and trends" Remove constraint Descriptor: "Bristol-Myers Squibb Co. -- Forecasts and trends"
1,053 results on '"Bristol-Myers Squibb Co. -- Forecasts and trends"'

Search Results

201. Interstitial Lung Diseases Pipeline Insight | Key Companies - Roche, Bayer, Insmed, Avalyn Pharma, PureTech Health, Novartis, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics, and Others

202. Advanced Cervical Cancer Pipeline 2023 | Key Companies - AstraZeneca, GlaxoSmithKline, Advaxis, Bristol-Myers Squibb, Innovent Biologics, Shanghai Henlius Biotech, Genexine, Inc., Merck, and Others

203. Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others

204. Advanced Gastric Carcinoma Pipeline 2023 | Key Companies - BeiGene, Bristol-Myers Squibb, Hanmi Pharmaceutical, AstraZeneca, Genentech, Seagen Inc, Bicycle Tx Limited, Vedanta Biosciences Inc, and othe

205. Psoriatic Arthritis Market to Register Immense Growth During the Forecast Period (2022-2032) - DelveInsight | Key Companies - AbbVie, UCB Biopharma, BMS, Affibody AB, AltruBio, Sun Pharma, Janssen

206. Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio

207. Eosinophilic Esophagitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Key Companies - Regeneron, Sanofi, Bristol-Myers, Astrazeneca

208. Global Small Molecule API Market Report 2023: Growing Demand for Small Molecule Drugs Fuels the Sector

209. PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market

210. PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market

211. Merkel Cell Carcinoma Market Size & Share, Epidemiology & Competitive Analysis Report 2032 | Companies - Bristol-Myers Squibb, Incyte corporation, Kartos Therapeutics, NantKwest

212. Multiple Myeloma Market Analysis, Market Size, Epidemiology, Leading Companies | Companies - BMS, AstraZeneca, Pfizer, Array Biopharma, BioLineRx, MorphoSys AG, I-Mab Biopharma, Chipscreen Biosciences

213. Examining the Latest Breakthroughs in the Advanced Merkel Cell Carcinoma Pipeline| Key Companies - Exelixis, Bristol-Myers Squibb, and Others

214. Self-Injections Global Market Report 2023

215. Multiple Myeloma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Key Companies - Roche, AbbVie, Janssen Pharmaceutical, Regeneron Pharma

216. Global Analgesics Market Report 2023: Sector is Expected to Reach $67.4 Billion by 2028 at a CAGR of 4.49% - ResearchAndMarkets.com

217. Global Analgesics Market Report 2023: Sector is Expected to Reach $67.4 Billion by 2028 at a CAGR of 4.49%

218. DelveInsight Evaluates a Robust Waldenstrom's Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain

219. Advanced Gastric Carcinoma Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies - Bristol-Myers Squibb, AstraZeneca, Genentech, and Others

220. Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis

221. Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis

222. DelveInsight Highlights Major Metastatic Melanoma Pipeline Therapies and 75+ Leading Players Wheeling the Hypertension Pipeline Landscape

223. 75+ Leading Players Wheeling the Major Depressive Disorder Pipeline Landscape 2023 | Companies - Bristol-Myers Squibb, Janssen and Others

224. Propulsion of Multiple Sclerosis Pipeline as Novel and Extensive 100+ Therapies Likely to Enter in the Treatment Domain | Major Companies - Biogen, Takeda, Gilead Sciences, and Others

225. Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth - ResearchAndMarkets.com

226. Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth

227. 135+ Active Companies working to develop 150+ Pipeline Therapies for Non-Small Cell Lung Cancer Treatment Landscape | Major Companies - AbbVie, Pfizer, Bayer, Imugene, and Others

228. DelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline Landscape

229. Anaplastic Thyroid Cancer Drugs Market size to grow at a CAGR of 5.44% from 2021 to 2026, Driven by the high prevalence of thyroid cancer - Technavio

230. Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio

231. Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026; Astellas Pharma Inc., Athersys Inc., among others, emerge as key vendors - Technavio

232. BRAF Mutant Metastatic Melanoma Market Evolving at a Rapid Pace, Estimates DelveInsight | Key Companies Active in the Domain - Merck Sharp & Dohme, Eisai, Iovance Biotherapeutics, Genentech, Amgen, AstraZeneca, Pfizer, and Others

233. Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market

234. Antimicrobial Therapeutics Market size to grow by USD 51.4 billion from 2022 to 2027, Driven by initiatives from government agencies in the pharmaceutical industry - Technavio

235. Deep Vein Thrombosis Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - Bayer, Abbott Labs, Bristol-Myers Squibb, Pfizer, Sanofi

236. Systemic Lupus Erythematous Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Companies - AstraZeneca, Eli Lilly and Company, UCB Pharma

237. Non-small Cell Lung Cancer Drugs Market size to grow by USD 30.23 billion from 2021 to 2026, Driven by the increasing prevalence and incidence of non-small cell lung cancer - Technavio

238. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics

239. Non-small Cell Lung Cancer Drugs Market size to grow by USD 30.23 billion from 2021 to 2026, Driven by the increasing prevalence and incidence of non-small cell lung cancer - Technavio

240. Rich Insights into the Heart Failure Clinical Trial Analysis Featuring 75+ Companies and Therapies | DelveInsight

241. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics - ResearchAndMarkets.com

242. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics

243. Germany Cell and Gene Therapy Market - Focused Insights 2023-2028: Sector to Reach $3.44 Billion by 2028 at a 40% CAGR

244. Europe Cell and Gene Therapy Market Report 2023: Drug Developers Prioritize CAR-T Cell-Based Therapies with Over 1000 Trials Ongoing

245. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR

246. Germany Cell and Gene Therapy Market - Focused Insights 2023-2028: Sector to Reach $3.44 Billion by 2028 at a 40% CAGR

247. Europe Cell and Gene Therapy Market Report 2023: Government, as Well as Industrial and Academic Financing and Collaboration Among Small and Large Biopharmaceutical Companies Bolsters Sector

248. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR - ResearchAndMarkets.com

249. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR

250. Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio

Catalog

Books, media, physical & digital resources